TA47 Acute coronary syndromes - glycoprotein IIb/IIIa inhibitors (review): guidance
This document shows the full guidance on the use of glycoprotein llb/llIa inhibitors in the treatment of acute coronary syndromes.
|
TA47 Acute coronary syndromes - glycoprotein IIb/IIIa inhibitors (review): guidance
05 September 2002 (148.87 Kb 43 sec) |
